Proteases perform a fundamental role in protein regulation. Altered activity of lysosomal cathepsins, a class of protease, can indicate many disease-related processes, such as those involved in cancer, inflammation, arthritis, cardiovascular and many others. The ability to detect and quantify normal as well as altered protease cathepsin activity in vivo allows the progress and severity of these disease states to be tracked and interrogated over time.
Revvity’s IVISense™ Pan Cathepsin fluorescent probes (ProSense®) are versatile pan-cathepsin-activatable NIR agents for imaging various disease-related events. These activatable probes are optically silent in their intact state and become highly fluorescent following protease-mediated cleavage and activation.
For research use only. Not for use in diagnostic procedures.
Feature | Specification |
---|---|
Unit Size | 1 Vial (10 doses) |
Proteases perform a fundamental role in protein regulation. Altered activity of lysosomal cathepsins, a class of protease, can indicate many disease-related processes, such as those involved in cancer, inflammation, arthritis, cardiovascular and many others. The ability to detect and quantify normal as well as altered protease cathepsin activity in vivo allows the progress and severity of these disease states to be tracked and interrogated over time.
Revvity’s IVISense™ Pan Cathepsin fluorescent probes (ProSense®) are versatile pan-cathepsin-activatable NIR agents for imaging various disease-related events. These activatable probes are optically silent in their intact state and become highly fluorescent following protease-mediated cleavage and activation.
For research use only. Not for use in diagnostic procedures.
IVISense Pan Cathepsin 750 FAST is a member of a family of activatable fluorescent imaging agents comprising a novel architecture, termed F.A.S.T. (Fluorescent Activatable Sensor Technology) that confers an improved pharmacokinetic profile with a broader range of early imaging time points. This architecture also offers higher target specific signal with reduced background. IVISense Pan Cathepsin 750 FAST offers faster activation after injection; it can be imaged at earlier times for optimized work flow, or for applications such as acute inflammation models. 4-24h imaging at 750 nm.
Brand |
IVISense
|
---|---|
Fluorescent Agent Type |
Activatable
|
Imaging Modality |
Fluorescence
|
Shipping Conditions |
Shipped in Blue Ice
|
Style |
FAST
|
Therapeutic Area |
Arthritis
Atherosclerosis
Inflammation
Oncology/Cancer
|
Unit Size |
1 Vial (10 doses)
|
Wave Length |
750 nm
|
Are you looking for resources, click on the resource type to explore further.
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...
We are here to answer your questions.